RU2017137502A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017137502A3 RU2017137502A3 RU2017137502A RU2017137502A RU2017137502A3 RU 2017137502 A3 RU2017137502 A3 RU 2017137502A3 RU 2017137502 A RU2017137502 A RU 2017137502A RU 2017137502 A RU2017137502 A RU 2017137502A RU 2017137502 A3 RU2017137502 A3 RU 2017137502A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/812—Breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/828—Stomach
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16141—Use of virus, viral particle or viral elements as a vector
- C12N2760/16142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015901375A AU2015901375A0 (en) | 2015-04-17 | A vaccine composition and uses thereof | |
| AU2015901375 | 2015-04-17 | ||
| PCT/AU2016/050275 WO2016164980A1 (en) | 2015-04-17 | 2016-04-15 | A vaccine composition and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017137502A RU2017137502A (ru) | 2019-05-17 |
| RU2017137502A3 true RU2017137502A3 (enExample) | 2019-09-16 |
| RU2726411C2 RU2726411C2 (ru) | 2020-07-14 |
Family
ID=57125491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017137502A RU2726411C2 (ru) | 2015-04-17 | 2016-04-15 | Вакцинная композиция и ее применения |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10532090B2 (enExample) |
| EP (1) | EP3283105B1 (enExample) |
| JP (1) | JP6957448B2 (enExample) |
| KR (1) | KR102372615B1 (enExample) |
| CN (1) | CN108025061B (enExample) |
| AU (1) | AU2016250289B2 (enExample) |
| ES (1) | ES2908071T3 (enExample) |
| NZ (1) | NZ736194A (enExample) |
| RS (1) | RS63080B1 (enExample) |
| RU (1) | RU2726411C2 (enExample) |
| SG (1) | SG11201708247XA (enExample) |
| TW (1) | TWI740823B (enExample) |
| WO (1) | WO2016164980A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019116089A2 (en) * | 2017-12-11 | 2019-06-20 | Medizinische Universitaet Wien | A method of producing a vaccine composition and uses thereof |
| JP2021512966A (ja) * | 2018-02-07 | 2021-05-20 | イミュジーン、リミテッドＩｍｕｇｅｎｅ Ｌｉｍｉｔｅｄ | ワクチン組成物およびその使用 |
| WO2022133447A1 (en) * | 2020-12-16 | 2022-06-23 | Dynavax Technologies Corporation | Method for quantifying cpg-containing oligonucleotides in formulations comprising alum |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0739984A1 (en) * | 1995-04-26 | 1996-10-30 | San Tumorforschungs-Gmbh | Bivalent polypeptides containing at least two domains |
| GB9808932D0 (en) * | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
| JP4658423B2 (ja) * | 1999-08-03 | 2011-03-23 | ザ オハイオ ステイト ユニバーシティ | Ｈｅｒ−２タンパク質に対する免疫反応性を増強するためのポリペプチドおよびポリヌクレオチド |
| ES2394293T3 (es) | 2001-02-28 | 2013-01-30 | Bio Life Science Forschungs- Und Entwicklungsges.M.B.H. | Vacuna contra cánceres que están asociados con el oncogén HER-2/neu |
| WO2005021710A2 (en) | 2003-06-02 | 2005-03-10 | University Of Miami | Chimeric molecules and methods of use |
| ATE473758T1 (de) | 2006-04-13 | 2010-07-15 | Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh | Her-2/neu multipeptidimpfstoff |
| EP2292258A1 (en) * | 2009-08-18 | 2011-03-09 | Pevion Biotech Ltd. | Multiepitope vaccine for Her2/neu-associated cancers |
| EP2659906A1 (en) * | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| PT2668959E (pt) * | 2012-05-31 | 2015-02-05 | Innavirvax | Compostos imunogénicos compreendendo o péptido gp41 do vih acoplado à proteína transportadora crm197 |
| WO2016007499A1 (en) * | 2014-07-07 | 2016-01-14 | Duke University | Vaccines against an oncogenic isoform of her2 (erbb2) and methods of using the same |
-
2016
- 2016-04-15 RU RU2017137502A patent/RU2726411C2/ru active
- 2016-04-15 US US15/316,868 patent/US10532090B2/en active Active
- 2016-04-15 JP JP2018505505A patent/JP6957448B2/ja active Active
- 2016-04-15 EP EP16779340.5A patent/EP3283105B1/en active Active
- 2016-04-15 TW TW105111976A patent/TWI740823B/zh active
- 2016-04-15 ES ES16779340T patent/ES2908071T3/es active Active
- 2016-04-15 WO PCT/AU2016/050275 patent/WO2016164980A1/en not_active Ceased
- 2016-04-15 CN CN201680029118.4A patent/CN108025061B/zh active Active
- 2016-04-15 NZ NZ736194A patent/NZ736194A/en unknown
- 2016-04-15 SG SG11201708247XA patent/SG11201708247XA/en unknown
- 2016-04-15 AU AU2016250289A patent/AU2016250289B2/en active Active
- 2016-04-15 KR KR1020177032987A patent/KR102372615B1/ko active Active
- 2016-04-15 RS RS20220204A patent/RS63080B1/sr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201708247XA (en) | 2017-11-29 |
| JP6957448B2 (ja) | 2021-11-02 |
| KR102372615B1 (ko) | 2022-03-08 |
| RS63080B1 (sr) | 2022-04-29 |
| RU2726411C2 (ru) | 2020-07-14 |
| BR112017021981A2 (pt) | 2018-07-10 |
| US10532090B2 (en) | 2020-01-14 |
| RU2017137502A (ru) | 2019-05-17 |
| AU2016250289A1 (en) | 2017-01-05 |
| KR20180003560A (ko) | 2018-01-09 |
| EP3283105A1 (en) | 2018-02-21 |
| ES2908071T3 (es) | 2022-04-27 |
| JP2018511659A (ja) | 2018-04-26 |
| CN108025061A (zh) | 2018-05-11 |
| HK1248536A1 (zh) | 2018-10-19 |
| US20170119867A1 (en) | 2017-05-04 |
| NZ736194A (en) | 2022-08-26 |
| TW201705978A (zh) | 2017-02-16 |
| AU2016250289B2 (en) | 2017-03-02 |
| EP3283105B1 (en) | 2022-01-26 |
| CN108025061B (zh) | 2022-02-15 |
| WO2016164980A1 (en) | 2016-10-20 |
| TWI740823B (zh) | 2021-10-01 |
| EP3283105A4 (en) | 2018-12-19 |